Latest News and Press Releases
Want to stay updated on the latest news?
-
Sanofi va acquérir Dynavax et ajouter un vaccin commercialisé contre l’hépatite B pour adultes et un candidat vaccin de phase 1⁄2 contre le zona au pipeline Paris, le 24 décembre 2025. Sanofi a...
-
Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline Paris, December 24, 2025. Sanofi announced today that it has entered into an...
-
PHILADELPHIA, Dec. 22, 2025 (GLOBE NEWSWIRE) -- via IBN -- Datavault AI Inc. (“Datavault AI” or the “Company”) (NASDAQ: DVLT), a pioneer in AI-driven data valuation, monetization, and...
-
PHILADELPHIA, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Datavault AI Inc. (NASDAQ: DVLT; the “Company” or “Datavault AI”), a leading provider of patented agentic AI platforms for data observation, valuation...
-
Billings, Montana, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Bion Environmental Technologies, Inc. (OTC QB: BNET), a leader in advanced fertilizers produced from manure and other organic waste, announced...
-
Entered into an exclusive license agreement with Dynavax for the Company’s COVID-19 oral pill vaccine candidate for potential cumulative proceeds of up to $700 million plus royalties Completed...
-
Australian needle-free vaccine patch company Vaxxas appoints global pharmaceutical executive to Board as it accelerates product to market.
-
Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Oncology Adjuvants Market Report 2025" report has been added to ResearchAndMarkets.com's offering.The oncology adjuvants market size has grown...
-
Dublin, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The "Shingles Vaccine Market Report 2025" report has been added to ResearchAndMarkets.com's offering.The shingles vaccine market size has grown rapidly in...
-
Immune response successfully improved with second generation vaccine candidate Saint-Herblain (France), November 4, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company,...